🔬 Experimental Drug CS18 Shows Promise For Overcoming
Published by OOPSONLINE.IN · Source: News-Medical.net · 1 min read · · Updated
What actually happened
Researchers at Baylor College of Medicine have developed a drug called CS18 that disrupts the ability of cancer cells to survive therapy. The findings, published in Science Advances, support exploring the possibility of using CS18 to treat human cancer in the future.
Key points
- Researchers at Baylor College of Medicine have developed a drug called CS18 that disrupts the ability of cancer cells to survive therapy.
- The findings, published in Science Advances, support exploring the possibility of using CS18 to treat human cancer in the future.
Summary based on data provided by News-Medical.net. Full article available at the original publisher.
- #science
- #experimental
- #drug